You know the only thing that has changed is the Rett trial. That was expected to be a clear success and it wasn't. Whether it was a clear fail will be decided by the FDA. We don't have the answer to that yet.
AD is still moving forward and a new trial for 3-71 has be initiated.
It may not be WGT and it still looks pretty good to me.
News 
Market Data 
Discover 
AI
